Rapid Micro Biosystems Reports Fourth Quarter and Full Year 2023 Financial Results and Provides 2024 Guidance [Yahoo! Finance]
Rapid Micro Biosystems, Inc. - Class A (RPID)
NASDAQ:AMEX Investor Relations:
money.cnn.com/news/newsfeeds/articles/marketwire/0649788.htm
Company Research
Source: Yahoo! Finance
Reports revenue of $22.5 million , representing growth compared to 2022 Delivered recurring revenue of $13.5 million , representing growth compared to 2022 Provides 2024 revenue guidance of at least $27.0 million, representing at least 20% growth compared to 2023 LOWELL, Mass., March 01, 2024 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products, today announced its financial results for the fourth quarter and full year ended December 31, 2023. Recent Highlights Strong fourth quarter 2023 revenue growth of 45% compared to the fourth quarter of 2022. Placed six Growth Direct systems in the fourth quarter; highest placements since the third quarter of 2021. Growth Direct systems now placed with 100% of commercially approved CAR-T therapy manufacturers. Announced e
Show less
Read more
Impact Snapshot
Event Time:
RPID
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
RPID alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
RPID alerts
High impacting Rapid Micro Biosystems, Inc. - Class A news events
Weekly update
A roundup of the hottest topics
RPID
News
- Global Rapid Microbiology Testing Market Report 2024-2029: Revenue Shift & Revenue Pockets for Rapid Microbiology Testing Market [Yahoo! Finance]Yahoo! Finance
- Rapid Microbiology Testing Market is Expected to Reach $8.3 billion | MarketsandMarkets™ [Yahoo! Finance]Yahoo! Finance
- Rapid Micro Biosystems to Announce First Quarter 2024 Financial Results on May 3, 2024GlobeNewswire
- Rapid Microbiology Testing Market Worth $8.3 billion | MarketsandMarkets™ [Yahoo! Finance]Yahoo! Finance
- Rapid Micro Biosystems to Exhibit at the 2024 PDA Annual Meeting from March 25 - 27, 2024 [Yahoo! Finance]Yahoo! Finance
RPID
Earnings
- 3/1/24 - Beat
RPID
Sec Filings
- 4/9/24 - Form ARS
- 4/9/24 - Form DEFA14A
- 4/9/24 - Form DEF
- RPID's page on the SEC website